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Abstract
BACKGROUND: Atherosclerosis is a widespread and devastating disease and one of the leading causes of death 
worldwide. So much is there to understand about atherosclerosis. And although a lot is already discovered, yet most 
of the studies are performed in cell cultures and animal models. Recent technologies for genetic engineering and 
imaging are mainly performed on animal models, with few studies in human tissues. A better understanding of their 
role is required. 
AIM: We aim to study the expression of CD 34 hematopoietic progenitor stem cell, CD 68 macrophages, and 
smooth muscle actin (SMA)-positive smooth muscle cells (SMCs) in the human coronary arteries and correlate their 
differential expression with the atherosclerosis progression.
RESULTS: CD 68 and CD 34 expression increase as the atherosclerotic process proceeds from early atheroma to 
advanced atheroma and start to decrease as the process proceeds to fibroatheroma with a significant p < 0.001. 
Conversely, SMA expression decreases as the atherosclerotic process progresses with a significant p < 0.001.
CONCLUSION: CD34 progenitor cells in conjunction with CD 68 macrophages have a major role in the development 
of atherosclerosis, whereas the SMCs are minimal in the early stages and reach their maximal levels during the 
stage of fibroatheroma.
Introduction
Atherosclerosis remains an increasingly 
important disease worldwide. It accounts for nearly 
one-third of deaths in ages over 35 years [1]. Despite 
the tremendous progress in biomedical sciences, it is 
still considered one of the great challenges in medicine 
due to its complex pathogenesis [2].
Atherosclerosis produces slow coronary 
narrowing resulting in stable angina and pain on 
exertion. Furthermore, the plaque rupture produces 
acute coronary syndromes presenting as unstable 
angina, myocardial infarction, or even sudden death [3].
Various risk factors, such as obesity, diabetes 
mellitus, hypertension, stress, cigarette smoking, 
hypercholesterolemia, gout, and familial predisposition 
can affect the progression of atherosclerosis [4], [5].
It is agreed on that atherosclerosis starts 
with endothelial dysfunction then increased adherence 
of monocytes/macrophages and T-lymphocytes. 
Monocyte/macrophage infiltrate in the sub-endothelial 
space accompanied by serum lipid permeation, then 
the migration of medial smooth muscle cells (SMC) into 
the intima [6].
In addition to their role in lipid uptake, 
macrophages have a central role in the inflammatory 
response involved in plaque progression [7].
Accumulating evidence suggests that subset 
of hematopoietic stem cells circulating in the blood is 
involved in atherogenesis. Zulli et al. (2005) on their 
experimental study on rabbits reported that CD34-
positive cells are present within the atherosclerotic 
plaques of rabbits fed high dietary cholesterol [8]. 
Recently, a role of CD 34 was detected in inflammatory-
erosive plaques [9].
The vascular SMCs (VSMCs) comprise a major 
contributor to atherosclerotic plaque development and 
progression. They have been detected at all stages of 
atherosclerosis [10]. It has been noticed that there is an 
interplay between CD34-positive hematopoietic cells 
with SMCs and macrophage in a rabbit atherosclerotic 
model [8].
Furthermore, a more recent study by Kruzliak 
et al. (2016) has reported that the predominant cell 
population in a fibrous cap was the VSMCs CD34 
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(−ve)/smooth muscle actin (SMA) (+ve). Few CD34 
(+ve)/SMC (+ve) cells were also present in a similar 
animal model [11].
Relatively recent studies suggest that small, 
non-stenotic atherosclerotic lesions account for the 
majority of ruptured plaques [12]. This worrisome 
postulation needs to be investigated. However, it 
seems that the experimental animal models have 
not provided a full explanation of the atherosclerosis 
progression. In humans, we mainly rely on 
epidemiological studies [13].
Herein, we decided to perform a postmortem 
study on human coronaries. We aim to examine the 
role of CD34 hematopoietic stem cells in human 
atherosclerotic tissues and to compare their role with 
that of macrophages and SMCs in various stages of 
atherosclerosis. This may shed some light on the role 
of these three main contributors of atherosclerosis on 
atherogenesis and plaque progression.
Materials and Methods
Study design
A cross-sectional observational study was 
conducted in the pathology department of the Egyptian 
Forensic Medicine Authority (EFMA). It included 
coronary artery segments obtained from 61 autopsy 
cases admitted to the Pathology Department in the 
period between 2014 and 2015.
Anonymous data are collected including the 
age, gender, and residence of the deceased. The gross 
and microscopic findings of the examined hearts were 
recorded, together with the reported causes of deaths. 
The study and all the procedures were approved by the 
EFMA.
Heart and coronary dissection
The hearts were weighed, measured, and 
externally examined to assess the cardiac and 
pericardial external gross appearance [Figure (A-1)]
The course and pattern of the coronary arteries 
were assessed [14]
The coronary arteries were serially cut by 
transverse incisions, 3–5 mm interval [15]
We started with the common left coronary 
(LCA), then the anterior descending branch – the 
continuity of the LCA. Then, circumflex and the right 
coronary artery were followed
If a gross pathology was noticed, sections 
taken may reach 10-15 from one coronary.
Tissues
After samples were excised, they were fixed in 
10% neutral-buffered formalin
Tissue sections, from coronaries, were routinely 
processed and embedded in paraffin
Paraffin blocks are made and serial sections of 
4 micron thickness are prepared. Sections are stained 
with H&E for routine microscopic examination.
Histopathological evaluation
The degree of stenosis of the coronary was 
reported and the grade of the atheroma was evaluated
Histological typing of atherosclerotic lesions 
followed the American Heart Association classification [16]:
Early lesions are types I, II, and III (25 
coronaries)
Advanced lesions are types IV, V, and VI (36 
coronaries).
Selection of sections for 
immunohistochemistry
Finally, sections of the coronary arteries were 
submitted for immunohistochemical staining by CD 34, 
CD 68, and SMA.
Immunohistochemistry
Histological sections approximately 4 µm thick 
were deparaffinated in xylene and alcohol and then 
rehydrated in distilled water for 5 min. Then, they were 
washed in PBS for 5 min
Sections were pretreated with the proteolytic 
enzyme proteinase K (Dako, Copenhagen, Denmark), 
for antigen retrieval. This was followed by a wash in 
PBS for 5 min
Non-immune protein blocking serum was 
added and incubated in a humid chamber
Primary antibodies for CD34, CD68, and SMA 
(Dako, Copenhagen, Denmark) were used
The primary monoclonal antibodies CD34, 
CD68, and SMA were incubated for 60 minutes at 37°C, 
followed by PBS wash for 5 min
The secondary antibody was applied for 60 
min (Dako, Copenhagen, Denmark)
Two drops of the horseradish peroxidase-
conjugated streptavidin were added followed by 
incubation for 60 min. Then, rinsing with PBS was 
done
Finally, the reaction was visualized with DAB 
chromogen (Dako, Copenhagen, Denmark)
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Slides were counterstained with dilute 
hematoxylin, rinsed with ammonia, and then with tap 
water. Sections were dehydrated with graded ethanol, 
cleared in xylene, and then coverslipped.
Immunohistochemical Evaluation
The distribution of staining for CD34, CD68, 
and SMA is assessed in every section
Manual counting of positively stained cells in 
the most advanced lesion in the atheromatous plaque 
is performed using fields at x400. As regard the SMCs, 
the counted cells are those proliferating cells within 
the atheromatous plaque. The stained regular mature 
SMCs of the media are omitted.
Statistical Analysis
All results are expressed as the mean standard 
errors of the mean. Statistical analysis is conducted 
using an analysis of variance using SPSS v 16. Results 
are considered to be statistically significant at p < 0.05.
Results
The results are summarized in Tables 1-3.
The age ranged from 4th to 8th decade, nine 
cases are in the 4th decade (14.8%), 25 are in the 5th 
decade (41%), 12 are in the 6th decade (19.7%), 10 
are in the 7th decade (16.4%), two are in the 8th decade 
(3.3%), and three cases are unknown (4.9%).
Advanced atheroma is more prevalent in the 
4th decade; while fibroatheroma is more detected in the 
6th decade. Calcified atheromatous plaques are more 
encountered in the 7th decade.
This study included 61 cases, 91.8% are male, 
3.3% are female, and 4.9% had no available data 
(referred anonymously to the laboratory).
Regarding the grade of atherosclerosis in 
a given coronary artery, 12 (19.7%) arteries show 
early atherosclerotic changes, 13 (21.3%) arteries 
show atheroma type III, and two cases (3.3%) have 
advanced atheromas, and type IV, one of which showed 
obstructed lumen by a recent thrombus. Thirty-four 
(55.7%) arteries have fibroatheromas and complicated 
fibroatheromas, types V and VI. 
Table 1: CD68 expression in the atherosclerotic plaque with relation to the grade of atherosclerosis
Variables N Mean SD. 95% confidence interval for mean Minimum Maximum p-value
Lower bound Upper bound
Ruptured plaque (VI) 1 1.00 . . . 1 1 <0.001
Atheroma (I-CD68 IV) 27 49.56 17.603 42.59 56.52 15 77
Fibroatheroma (V) 33 7.58 9.549 4.19 10.96 1 40
Total 61 26.05 25.094 19.62 32.48 1 77
Figure 1: CD 34 expression in the atherosclerotic plaque with relation 
to the grade of atherosclerosis
Regarding the degree of stenosis, 15 (24.6%) 
cases are not associated with stenosis, 23 (37.7%) 
cases showed mild stenosis, 12 (19.7%) cases showed 
moderate stenosis, nine (14.8%) cases showed 
severe stenosis, and 2 (3.3%) cases showed complete 
occlusion of the coronary lumen.
Figure 2: SMA expression in the atherosclerotic plaque with relation 
to the grade of atherosclerosis
Eight (13.2%) cases were associated with 
calcification, one of which was associated with 
hemorrhage and rupture.
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as the process proceeds to fibroatheroma with 
significant p < 0.001 (Table 3 and Figure 3).
Figure 5: A) CD 68 strong expression in thrombosed vessel; B) CD 34 
strong expression in thrombosed vessel; C) Actin strong expression 
in thrombosed vessel
Discussion
Atherosclerosis is a slow progressive disease 
process that starts in childhood. It may progress rapidly 
in some individuals by their 30s. However, in others, 
it may only progress after the 5th decade. The exact 
pathogenesis of atherosclerosis and its progression are 
not well recognized.
Table 2: CD34 expression in the atherosclerotic plaque with 
relation to the grade of atherosclerosis
Variables N Mean SD 95% confidence 
interval for mean
Minimum Maximum p-value
Lower 
bound
Upper 
bound
Ruptured 
plaque (VI)
1 2.00 . . . 2 2 <0.001
Atheroma 
(I-IV) CD34
27 38.04 11.663 33.42 42.65 13 65
Fibroatheroma 
(V)
33 6.18 11.148 2.23 10.13 1 65
Total 61 20.21 19.545 15.21 25.22 1 65
According to our study, 91.8% of the cases 
were male. These results are biased by the fact that the 
number of susceptible females subjected to forensic 
autopsy in Egypt is much lesser than males. Thus, 
this figure does not reflect the actual epidemiological 
prevalence of the disease.
Figure 3: A) CD 68 strong expression in early atherogenesis; B) CD 34 
strong expression in early atherogenesis; C) Actin weak expression 
in atheroma (only the small proliferating small cells are counted
It was found that CD 68 expression increases 
as the atherosclerotic process proceeds from early 
atheroma to advanced atheroma and starts to decrease 
as the process proceeds to fibroatheroma with 
significant p < 0.001 (Table 1 and Figures 1 and 4).
Figure 4: A) CD 68 weak expression in fibroatheroma; B) CD 34 
Weak expression in fibroatheroma; C) Actin strong expression in 
fibroatheroma
CD 34 expression also increases as the 
atherosclerotic process proceeds from early atheroma 
to advanced atheroma, then starts to decrease as the 
process proceeds to fibroatheroma with significant p < 
0.001 (Table 2 and Figures 2 and 5).
It is noticed that SMA expression is minimal 
as the atherosclerotic process proceeds from early 
atheroma to advanced atheroma and starts to increase 
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Table 3: SMA expression in the atherosclerotic plaque with 
relation to the grade of atherosclerosis
Variables n Mean SD 95% confidence 
interval for mean
Minimum Maximum 
p-value
Lower 
bound
Upper 
bound
Ruptured plaque (VI) 1 50.00 . . . 50 50<0.001
Atheroma (I-Actin IV) 27 13.41 15.564 7.25 19.56 1 55
Fibroatheroma (V) 33 63.42 22.751 55.36 71.49 15 100
Total 61 41.07 31.647 32.96 49.17 1 100
In the present study, the most prevalent age 
for advanced atheroma is the 4th decade; the most 
prevalent age for fibroatheroma is the 6th decade 
while the most prevalent age for calcifications in the 
atheromatous plaque is the 7th decade. Thus, we have 
noticed lesional progression with age. Over 55% of the 
studied cases are under the age of 50.
Some studies claim that the plaques 
responsible for myocardial infarctions and other acute 
coronary syndromes often are asymptomatic before 
the acute event. The worrisome conclusion is that 
large numbers of asymptomatic individuals are at risk 
for a catastrophic coronary event [17]. One of the two 
reported cases of acute coronary syndrome showed 
only 60% stenosis (i.e., asymptomatic).
CD 68 is used as a marker for macrophages, 
CD 34 as a marker for the hematopoietic stem cells, 
and SMA as a marker for the SMCs.
Macrophages are considered the key promoters 
of the atherogenic process. A significant and independent 
correlation between blood monocyte-macrophage count 
and the atherosclerotic vascular disease in humans have 
been previously documented [18].
CD68 expression also increases in conjunction 
with the CD 34 expression as the atherosclerotic process 
proceeds from early atheroma to advanced atheroma 
and then the expression of both starts to decrease as 
the process proceeds to fibroatheroma (Figure 1).
The different cell types in the atherosclerotic 
plaque have always been a subject of debate 
amongst researchers in the field of medical research. 
Accumulating evidence indicates that bone marrow-
derived progenitor cells, including endothelial progenitor 
cells and smooth muscle progenitor cells, are involved in 
atherogenesis, and that these progenitors differentiate 
into mature and functional SMCs [19], [20].
Qingbo (2006) suggests that progenitor cells 
recruited from the blood and the vessel adventitia 
migrate into the intima, where they proliferate. This is 
enhanced by increased endothelial turnover, as well 
as the promotion of smooth muscle and macrophage 
accumulation in the plaques. Hence, the progenitor cells 
are thought to provide the main cell source responsible 
for the formation of atherosclerotic lesions [21].
This is strongly evident in our study as we have 
noticed an increased number of CD 34 in the intima and 
adventitia, of the atherosclerotic vessels, especially in 
the early atherogenesis (Figures 4 A1 and B1).
We have found that CD 34 expression 
increases as the atherosclerotic process proceeds 
from early atheroma to advanced atheroma and starts 
to decrease as the process proceeds to fibroatheroma 
(Figure 2).
Conversely, SMA expression is minimal as the 
atherosclerotic process proceeds from early atheroma 
to advanced atheroma and starts to increase as the 
process proceeds to fibroatheroma (Figure 3).
Feil et al., 2014, and Chappell et al., 2016, 
proposed that the SMC population of the intima is derived 
from a subset of medial SMC after vascular injury in 
experimental models of atherosclerosis [22], [23].
Grebe and Latz (2013) proposed that plaques 
with large numbers of foam cells and abundant 
extracellular lipid, as well as plaques that have thin 
fibrous caps containing few SMCs, and those that 
contain clusters of inflammatory cells are particularly 
high risk. Herein, increased expression of the three 
types of cells is noticed in these complicated lesions. 
This is in contrast to our findings in other stable plaque 
lesions, where the levels of CD 34 and CD 68 decline 
with plaque progression. Thus, a suggested role of these 
cells in plaque instability needs to be investigated [24].
Some experimental studies described these 
vulnerable plaques. As fibrous cap undergoes continuous 
remodeling; its stability is directly proportional to the 
collagen deposition. It is proposed that the balance of 
collagen synthesis and degradation affects cap integrity. 
Collagen in atherosclerotic plaques is synthesized 
primarily by SMCs, and loss of SMCs understandably 
results in cap weakening [25]. Again this is contradictory 
to our findings in these two cases of acute coronary 
syndrome where increased SMCs were detected in 
the complicated lesions. A previous study suggests 
that activated macrophages can accelerate the pro-
atherogenic functions of SMCs in plaques [26]. It was also 
suggested that dynamic interactions between SMCs and 
macrophages could affect the pathogenesis of plaques 
and the development of new classes of medical solutions 
[27]. Other studies attributed variable behaviors and roles 
of SMCs attributed to the variation in their embryological 
origins as well as their phenotypic switch [28].
In general, it is accepted that the inflammation 
promotes collagen degradation, thus destabilizing the 
plaque integrity. Stable plaques usually show a dense 
fibrous cap, with less inflammation, whereas unstable 
plaques have relatively thin caps and increased 
inflammatory infiltrates [17].
We recorded increased numbers of CD 34 
and CD 68-positive cells in complicated lesions. 
Furthermore, the degraded smooth muscles were 
increased in these complicated lesions (Figures 6).
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Conclusion
In conclusion, human progenitor stem cells 
and macrophages are increased with almost the same 
proportion during the progression of atherosclerosis 
till the stage of advanced atheroma where they both 
reach their maximum and then start to decrease till 
they both reach their minimal expression in the stage 
of fibroatheroma.
Meanwhile, the SMCs are minimal in the early 
stages and reach the lowest value during advanced 
atheroma stage and start to increase to reach their 
maximal levels during the stage of fibroatheroma.
The role of inflammatory cytokines is well 
noted as they activate the metalloproteinases leading 
to smooth muscle degradation resulting in plaque 
instability. Further immunopathologic studies on 
the types of inflammatory cytokines expressed in early 
atheromas can provide new therapeutic opportunities 
that can be used as prophylaxis from the acute coronary 
syndrome.
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Table A-1: Associations in heart muscle in the selected cases
Associations in heart Frequency Percent
Concentric hypertrophy only 1 1.6
Free 26 42.7
Chronic ischemia only 23 37.8
Infarction 10 16.3
Reperfusion injury 1 1.6
Total 61 100.0
Table A-3: Weight of the heart in the selected cases
Weight of heart Frequency Percent
150–<350 8 13.1
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Missing 3 4.9
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Table A-2: Exposure to trauma or stress among cases
Stress or trauma
Frequency Percent Valid percent Cumulative percent
No data 24 39.4 39.4 39.4
Stress 24 39.3 39.3 78.7
Trauma 13 21.3 21.3 100.0
Total 61 100.0 100.0
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Figure A-2: Mean weight of the heart in different degrees of 
atherosclerosis
Figure (A-1): Opening of coronary arteries transversely (a) and (b) 
inspection of coronary ostia, (c) LAD starting from the middle, (d) left 
main coronary, (e) left circumflex, (f) right coronary
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